Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial

NCT02655536 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Brain Neoplasms

Interventions

DRUG: Bevacizumab plus erlotinib
DRUG: Erlotinib

Sponsor

National Taiwan University Hospital